Based on the results of the evaluation of the above materials, the central executive authority implementing the state policy in the field of healthcare shall make a decision to approve or refuse the registration of a medicinal product within a period not exceeding ten working days. The decision to approve or refuse the registration of a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, shall be made within a period not exceeding seven working days. The decision to approve or refuse the registration of a medicinal product, subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the Ukrainian central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, shall be made based on the results of authenticity verification of registration materials for such a medicinal product, as provided by part five of this Article, within a period not exceeding seven working days. The review period of the above materials for a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, shall not exceed ten working days. The period of authenticity verification of registration materials for a medicinal product, subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the Ukrainian central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, shall not exceed seven working days. During the review of registration materials for a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, and the authenticity verification of registration materials for a medicinal product, subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the Ukrainian central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, expert evaluation of the registration dossier materials submitted to the regulatory authority that registered this medicinal product shall not be performed.